Literature DB >> 26159889

Age Does Matter: A Pilot Comparison of Placenta-Derived Stromal Cells for in utero Repair of Myelomeningocele Using a Lamb Model.

Erin G Brown1, Benjamin A Keller, Lee Lankford, Christopher D Pivetti, Shinjiro Hirose, Diana L Farmer, Aijun Wang.   

Abstract

INTRODUCTION: Fetal amniotic membranes (FM) have been shown to preserve spinal cord histology in the fetal sheep model of myelomeningocele (MMC). This study compares the effectiveness of placenta-derived mesenchymal stromal cells (PMSCs) from early-gestation versus term-gestation placenta to augment FM repair to improve distal motor function in a sheep model.
METHODS: Fetal lambs (n = 4) underwent surgical MMC creation followed by repair with FM patch with term-gestation PMSCs (n = 1), FM with early-gestation PMSCs (n = 1), FM only (n = 1), and skin closure only (n = 1). Histopathology and motor assessment was performed.
RESULTS: Histopathologic analysis demonstrated increased preservation of spinal cord architecture and large neurons in the lamb repaired with early-gestation cells compared to all others. Lambs repaired with skin closure only, FM alone, and term-gestation PMSCs exhibited extremely limited distal motor function; the lamb repaired with early-gestation PMSCs was capable of normal ambulation. DISCUSSION: This pilot study is the first in vivo comparison of different gestational-age placenta-derived stromal cells for repair in the fetal sheep MMC model. The preservation of large neurons and markedly improved motor function in the lamb repaired with early-gestation cells suggest that early-gestation placental stromal cells may exhibit unique properties that augment in utero MMC repair to improve paralysis.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26159889     DOI: 10.1159/000433427

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  15 in total

Review 1.  New directions in fetal surgery for myelomeningocele.

Authors:  Sandra K Kabagambe; Y Julia Chen; Melissa A Vanover; Payam Saadai; Diana L Farmer
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

Review 2.  Dural substitutes for spina bifida repair: past, present, and future.

Authors:  Marcos M Miyabe; Kendall P Murphy; Marc Oria; Soner Duru; Chia-Ying Lin; Jose L Peiro
Journal:  Childs Nerv Syst       Date:  2022-04-04       Impact factor: 1.475

3.  A Decade of Experience with the Ovine Model of Myelomeningocele: Risk Factors for Fetal Loss.

Authors:  Laura A Galganski; Kaeli J Yamashiro; Christopher D Pivetti; Benjamin A Keller; James C Becker; Erin G Brown; Payam Saadai; Shinjiro Hirose; Aijun Wang; Diana L Farmer
Journal:  Fetal Diagn Ther       Date:  2020-02-25       Impact factor: 2.587

4.  In utero treatment of myelomeningocele with placental mesenchymal stromal cells - Selection of an optimal cell line in preparation for clinical trials.

Authors:  Laura A Galganski; Priyadarsini Kumar; Melissa A Vanover; Christopher D Pivetti; Jamie E Anderson; Lee Lankford; Zachary J Paxton; Karen Chung; Chelsey Lee; Mennatalla S Hegazi; Kaeli J Yamashiro; Aijun Wang; Diana L Farmer
Journal:  J Pediatr Surg       Date:  2019-10-21       Impact factor: 2.545

Review 5.  Prenatal Neural Tube Anomalies: A Decade of Intrauterine Stem Cell Transplantation Using Advanced Tissue Engineering Methods.

Authors:  Alireza Soltani Khaboushan; Mehdi Shakibaei; Abdol-Mohammad Kajbafzadeh; Masoumeh Majidi Zolbin
Journal:  Stem Cell Rev Rep       Date:  2021-03-19       Impact factor: 5.739

Review 6.  Fetal myelomeningocele repair: a narrative review of the history, current controversies and future directions.

Authors:  Kaeli J Yamashiro; Diana L Farmer
Journal:  Transl Pediatr       Date:  2021-05

Review 7.  Modern fetal surgery-a historical review of the happenings that shaped modern fetal surgery and its practices.

Authors:  Lauren L Evans; Michael R Harrison
Journal:  Transl Pediatr       Date:  2021-05

Review 8.  State of the art in translating experimental myelomeningocele research to the bedside.

Authors:  Lourenço Sbragia; Karina Miura da Costa; Antonio Landolffi Abdul Nour; Rodrigo Ruano; Marcelo Volpon Santos; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2021-07-31       Impact factor: 1.475

Review 9.  Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.

Authors:  Raphael Gorodetsky; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 10.  Exosomal microRNAs from mesenchymal stem/stromal cells: Biology and applications in neuroprotection.

Authors:  Aida Nasirishargh; Priyadarsini Kumar; Lalithasri Ramasubramanian; Kaitlin Clark; Dake Hao; Sabrina V Lazar; Aijun Wang
Journal:  World J Stem Cells       Date:  2021-07-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.